Cargando…
Systematic Meta-Analysis Identifies Co-Expressed Kinases and GPCRs in Ovarian Cancer Tissues Revealing a Potential for Targeted Kinase Inhibitor Delivery
The use of many anticancer drugs is problematic due to severe adverse effects. While the recent clinical launch of several kinase inhibitors led to tremendous progress, these targeted agents tend to be of non-specific nature within the kinase target class. Moreover, target mediated adverse effects l...
Autores principales: | Albrecht, Hugo, Kübler, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781325/ https://www.ncbi.nlm.nih.gov/pubmed/31480803 http://dx.doi.org/10.3390/pharmaceutics11090454 |
Ejemplares similares
-
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022) -
Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines
por: Kübler, Eric, et al.
Publicado: (2018) -
The Open Question of How GPCRs Interact with GPCR Kinases (GRKs)
por: Cato, M. Claire, et al.
Publicado: (2021) -
Kinase Inhibitors and Ovarian Cancer
por: Katopodis, Periklis, et al.
Publicado: (2019) -
Biasing AlphaFold2 to predict GPCRs and kinases with user-defined functional or structural properties
por: Sala, Davide, et al.
Publicado: (2023)